The issue that no-one is really talking about is the impact this has on the entire E25 thesis.
We were supposed to be profitable from the get go.
This cashflow was to fund the battery grade expansion.
The delayed PFS is in my view - delayed so that this has time to sort itself out. They dont want to release the PFS and then say "ok so the PFS numbers are great we have to delay action because we have no money as our concentrate biz is still burning cash".
Either that or give a tonne of it away to a funding partner.
This has gone from a solid business with blue sky optionality - to a marginal business that needs alot to go right, just to get back to original base case.
I acknowledge this might be a washout low on poor sentiment - but for me the trust is gone and until I see evidence to the contrary Ill stand aside.
- Forums
- ASX - By Stock
- E25
- Ann: Revised Shipping Strategy Yields Substantial Cost Reduction
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Ann: Revised Shipping Strategy Yields Substantial Cost Reduction, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online